Therapeutics Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RACA research report →
About the company
Therapeutics Acquisition Corp. , which operates as Research Alliance Corp. I, was founded in 2020 and is headquartered in Boston, Massachusetts.
- CEO
- Peter Kolchinsky
- IPO
- 2020
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $1.09B
- P/E
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
- Revenue
- 0.00%
- Net Income
- 0.00%
- EPS
- 0.00%
- FCF YoY
- 0.00%
- 52W High
- $18.08
- 52W Low
- $9.81
- 50D MA
- $10.24
- 200D MA
- $11.99
- Beta
- 0.00
- Avg Volume
- 137.58K
Get TickerSpark's AI analysis on RACA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 21 | Kolchinsky Peter | other | 209,100 |
| Jun 29, 21 | RA CAPITAL MANAGEMENT, L.P. | buy | 209,100 |
| Jun 24, 21 | Kolchinsky Peter | other | 889,218 |
| Jun 23, 21 | RA CAPITAL MANAGEMENT, L.P. | other | 0 |
Our RACA coverage
Recent articles, reports, and earnings notes.
No research on RACA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RACA report →Similar companies
Peers in the same neighborhood.